European Society of Cardiology (ESC) guidance advises that treatment should last for at least six weeks in patients with ...

Andrzej Kutarski, M.D., PH.D; Barbara Małecka, M.D., PH.D; Agnieszka Kołodzinska, M.D., PH.D; Marcin Grabowski, M.D., PH.D In our subgroup of patients without ...

It is notable that the ECG obtained at presentation showed the presumed sinus rhythm with first-degree atrioventricular block (PR interval, 230 milliseconds), along with right bundle-branch block and ...

Adagio Medical (Nasdaq:ADGM) today announced the first completed procedure in an FDA IDE study of its VT cryoablation system.

And then Mike Koffler, Vice President of Finance will review the third quarter, 2024 financial results. Then we will be joined by Bob Duggan, cochair of the board, Darren Eker, Chief Technology ...

Congestive heart failure is a disease state distinguished by the regular presence of both renal and hepatic abnormalities in drug handling. One such abnormality involves flaws in the process of ...

Holdings announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration FDA Pivotal ...

EBR Systems' WiSE technology is the world's only wireless, endocardial (inside the heart) pacing system in clinical use for ...

Adagio Medical Holdings, Inc. (Nasdaq: ADGM; "Adagio Medical", "Adagio" or the "Company"), a leading innovator in catheter ablation technologies, today announced the completion of the first procedures ...

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary ...